January 30, 2015 3:08 AM ET

Capital Markets

Company Overview of The Biotech Growth Trust PLC

Company Overview

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched and managed by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

601 Lexington Avenue

54th Floor

New York, NY 10022

United States

Founded in 1997

Phone:

212-739-6400

Fax:

212-739-6444

Key Executives for The Biotech Growth Trust PLC

Portfolio Manager
Partner and Co-Portfolio Manager
Portfolio Manager
Age: 69
Portfolio Manager
Compensation as of Fiscal Year 2014.

The Biotech Growth Trust PLC Key Developments

The Biotech Growth Trust plc Announces Earnings Results for the First Six Months Ended September 30, 2014

The Biotech Growth Trust PLC announced earnings results for the first six months ended September 30, 2014. The company has reported a profit of GBP 64.47 million, or 96.5 pence per share, for the first six months ended September 30, 2014, compared to GBP 45.52 million, or 67.3 pence per share, for the same period ended September 30, 2013. Total income for the first six months ended September 30, 2014 was GBP 509,000, compared to GBP 477,000 for the same period ended September 30, 2013. Profit before finance costs and taxation for the first six months ended September 30, 2014 was GBP 64.60 million, compared to GBP 45.58 million for the same period ended September 30, 2013.

The Biotech Growth Trust plc Appoints Ernst & Young LLP as Auditor

The Biotech Growth Trust plc announced following the explanatory note to resolution 10 within the notice of the 2014 Annual General Meeting the Board of Directors of the company has now concluded the terms of engagement of the company's new auditors for the 2014/2015 financial year and has appointed Ernst & Young LLP.

The Biotech Growth Trust PLC Reports Audited Earnings Results for the Year Ended March 31, 2014

The Biotech Growth Trust PLC reported audited earnings results for the year ended March 31, 2014. For the year, the company reported total income of GBP 873,000 against GBP 570,000 for the same period in the last year. Profit before finance costs and taxation was GBP 86,525,000 against GBP 76,224,000 for the same period in the last year. Profit before taxation was GBP 86,431,000 against GBP 76,206,000 for the same period in the last year. Profit was GBP 86,337,000 or 126.8 pence per basic and diluted share against GBP 76,148,000 or 121.1 pence per basic and diluted share for the same period in the last year. Net asset value per share was 498.7 pence as at March 31, 2014 against 371.7 pence as at March 31, 2013. Net cash outflow from operating activities was GBP 52,246,000 against net cash inflow from operating activities of GBP 1,154,000 for the same period in the last year.

Similar Private Companies By Industry

Company Name Region
Bay Biotech Consulting, LLC United States
DNH Capital, L.L.C. United States
Healthcare Capital & Mergers, LLC United States
BofA Merrill Lynch Preferred Funding VI LP United States
MeritViewPartners LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The Biotech Growth Trust PLC, please visit www.frostrow.com/clients/biotech. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.